earnings
confidence high
sentiment positive
materiality 0.80
Medtronic Q4 rev $9.8B (+6.6% organic), non-GAAP EPS $1.55; dividend raised to $0.72
Medtronic plc
- Q4 revenue $9.807B, +9.9% reported / +6.6% organic; GAAP EPS $0.96, non-GAAP EPS $1.55.
- FY26 revenue $36.364B, +8.4% reported / +5.8% organic; GAAP EPS $3.73, non-GAAP EPS $5.53.
- Dividend increased to $0.72/quarter ($2.88 annual), payable July 17, 2026; 49th consecutive annual increase.
- FY27 guidance: organic revenue growth 6.75%-7.25%, non-GAAP EPS $5.90-$6.00.
- Cardiac Ablation Solutions revenue +78% globally; Hugo RAS submission filed with FDA for general surgery/gyn.